| Title | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) |
|---|---|
| Disease/Condition | Kidney Diseases (incl Chronic Kidney Disease),Hematologic Diseases,Nephrology,Urologic Diseases,Anemia |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Matthew Abramowitz, MD |
| Contact Name | Cynthia Rivera |
| Contact Email | cynthia.rivera@einstein.yu.edu |
| IRB/Protocol Number | 17-02-43-01E |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Nephrology - Kidney |